Physician profile
Hammad Khan
NPI 1225414857
$1,749.52
in general payments reported to CMS, 2019-2025
5 companies · $1,185 in 2025
The $1,185 reported for 2025 was more than what 83% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.61 · 2020: $31.94 · 2022: $166 · 2023: $74.52 · 2024: $263 · 2025: $1,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $865 · Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $865.18 |
| Food and Beverage | $657.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,580.55 | 2020-2025 | Spravato, Xarelto |
| E.R. Squibb & Sons, L.L.C. | $53.89 | 2019-2022 | |
| Medtronic, INC. | $50.91 | 2022-2024 | Corevalve Evolut R |
| Janssen Scientific Affairs, LLC | $35.62 | 2023 | Invega Sustenna |
| Neurocrine Biosciences, INC. | $28.55 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.